Britain tries to cool AstraZeneca concerns as its CEO touts a new vaccine trial

Britain has asked its medicine regulator to assess the vaccine for a temporary supply, which could mean it's rolled out in the country before the end of the year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.